Turkey Overhauls Pharmaceutical Pricing: A Strategic Shift Toward Local Production
Türkiye, ilaç piyasasında kronikleşen tedarik sorunlarını aşmak ve yerli ilaç sanayisini canlandırmak amacıyla fiyatlandırma usul ve esaslarını kökten

Turkey has implemented a comprehensive overhaul of its pharmaceutical pricing regulations, aiming to resolve chronic supply shortages and revitalize the domestic drug industry. The new decree introduces a more dynamic and predictable framework designed to respond effectively to shifting market conditions.
Redefining Competition via Gradual Pricing
Moving away from the abrupt price drops that previously occurred upon the entry of the first generic drug, the new model introduces a staggered reduction to ensure sustainable revenue streams for manufacturers. Instead of an immediate drop to 60%, the following schedule will apply:
Strategic Incentives for Domestic Manufacturing
To reduce import dependency, additional pricing advantages have been introduced for locally manufactured generics based on their market share. Local producers reaching specific thresholds will face more limited price reductions.
Exchange Rate Mechanism and Commission Oversight
The periodic Euro value, the cornerstone of drug pricing, will be determined by the "Price Evaluation Commission." The implementation timeline for currency fluctuations is as follows:
This pricing revision is essentially a 'supply security' operation. By softening the price drops for generics and providing margins for local producers, the government aims to minimize the risk of medicines disappearing from the market under global inflationary pressures. Specifically, allowing upward Euro adjustments to hit prices within 5 days is a proactive measure to mitigate cash-flow risks for the industry.
Related News & Analysis
View All →
Iran Foreign Minister Accuses U.S. of Energy Market Manipulation

TÜRK-İŞ's Victory Day Message: Atatürk's Legacy and the Future of the Nation

Scale War in Capital Markets: Tera's 1000-Fold Capital Ceiling Gambit

Paramount‑Skydance Faces Turkish Competition Condition on Warner Bros. Discovery Takeover

Turkey’s Industrial & Tech Surge: Value Added Tops $250 Billion, Europe’s #1 in Steel and UAV Production

Norway’s 20-Unit Patria Armored Vehicle Order Signals a Shift in Northern European Defense Economics
Latest Market News
All News →
Americans Shun Digital Gold: Control and Micro‑Investing Take Center Stage

Lambda Secures $1 B Debt: A New Front in the Chip War

Heavy Data Calendar Sets Course for Turkey’s Economy
Russia Extends Diesel and Jet Fuel Export Ban: Deep Market Implications

Alex Gerko’s Record £895 Million Gain at XTX in 2025
